American Banking and Market News logo

The Latest Headlines at American Banking and Market News

Image about Coupang (NYSE:CPNG) Upgraded by Citigroup to “Buy”

Coupang (NYSE:CPNG) Upgraded by Citigroup to “Buy”

Citigroup upgraded shares of Coupang (NYSE:CPNG – Free Report) from a neutral rating to a buy rating in a research report report published on Monday, Marketbeat.com reports. They currently have $26.00 target price on the stock,... More of this article »
Image about Clipper Realty (NYSE:CLPR) Downgraded to “Underperform” at Raymond James

Clipper Realty (NYSE:CLPR) Downgraded to “Underperform” at Raymond James

Raymond James cut shares of Clipper Realty (NYSE:CLPR – Free Report) from an outperform rating to an underperform rating in a research report report published on Monday morning, MarketBeat Ratings reports. Separately, JMP Securities... More of this article »
Image about LENZ Therapeutics (NASDAQ:LENZ) Coverage Initiated by Analysts at SVB Leerink

LENZ Therapeutics (NASDAQ:LENZ) Coverage Initiated by Analysts at SVB Leerink

SVB Leerink started coverage on shares of LENZ Therapeutics (NASDAQ:LENZ – Free Report) in a research note published on Monday, MarketBeat Ratings reports. The brokerage issued an outperform rating and a $32.00 price objective... More of this article »
Image about NN (NASDAQ:NNBR) Coverage Initiated by Analysts at Noble Financial

NN (NASDAQ:NNBR) Coverage Initiated by Analysts at Noble Financial

Noble Financial initiated coverage on shares of NN (NASDAQ:NNBR – Free Report) in a research report sent to investors on Monday, Marketbeat reports. The firm issued an outperform rating and a $6.00 price objective on the industrial... More of this article »
Image about Mind Medicine (MindMed) (NASDAQ:MNMD) Coverage Initiated by Analysts at SVB Leerink

Mind Medicine (MindMed) (NASDAQ:MNMD) Coverage Initiated by Analysts at SVB Leerink

SVB Leerink began coverage on shares of Mind Medicine (MindMed) (NASDAQ:MNMD – Free Report) in a research report released on Monday morning, MarketBeat reports. The brokerage issued an outperform rating and a $20.00 target price... More of this article »
Image about Duke Energy (NYSE:DUK) Price Target Increased to $100.00 by Analysts at Barclays

Duke Energy (NYSE:DUK) Price Target Increased to $100.00 by Analysts at Barclays

Duke Energy (NYSE:DUK – Free Report) had its price objective hoisted by Barclays from $99.00 to $100.00 in a research note released on Monday morning, Benzinga reports. Barclays currently has an overweight rating on the utilities... More of this article »
Image about Ramaco Resources (NASDAQ:METC) Given New $24.00 Price Target at B. Riley

Ramaco Resources (NASDAQ:METC) Given New $24.00 Price Target at B. Riley

Ramaco Resources (NASDAQ:METC – Free Report) had its price objective reduced by B. Riley from $25.00 to $24.00 in a research note issued to investors on Monday morning, Benzinga reports. They currently have a buy rating on the... More of this article »
Image about Entergy (NYSE:ETR) Given New $107.00 Price Target at Barclays

Entergy (NYSE:ETR) Given New $107.00 Price Target at Barclays

Entergy (NYSE:ETR – Free Report) had its target price cut by Barclays from $108.00 to $107.00 in a research report report published on Monday morning, Benzinga reports. They currently have an equal weight rating on the utilities... More of this article »
Image about American Tower (NYSE:AMT) Given New $196.00 Price Target at Morgan Stanley

American Tower (NYSE:AMT) Given New $196.00 Price Target at Morgan Stanley

American Tower (NYSE:AMT – Free Report) had its target price upped by Morgan Stanley from $183.00 to $196.00 in a report issued on Monday morning, Benzinga reports. Morgan Stanley currently has an equal weight rating on the real... More of this article »
Image about Natera (NASDAQ:NTRA) Given New $100.00 Price Target at The Goldman Sachs Group

Natera (NASDAQ:NTRA) Given New $100.00 Price Target at The Goldman Sachs Group

Natera (NASDAQ:NTRA – Free Report) had its price objective upped by The Goldman Sachs Group from $90.00 to $100.00 in a report published on Monday morning, Benzinga reports. The brokerage currently has a buy rating on the medical... More of this article »
Image about AON (NYSE:AON) Given New $327.00 Price Target at Morgan Stanley

AON (NYSE:AON) Given New $327.00 Price Target at Morgan Stanley

AON (NYSE:AON – Free Report) had its price target increased by Morgan Stanley from $325.00 to $327.00 in a research report released on Monday, Benzinga reports. They currently have an equal weight rating on the financial services... More of this article »
Image about Neogen (NASDAQ:NEOG) Price Target Lowered to $17.00 at Piper Sandler

Neogen (NASDAQ:NEOG) Price Target Lowered to $17.00 at Piper Sandler

Neogen (NASDAQ:NEOG – Free Report) had its price target trimmed by Piper Sandler from $19.00 to $17.00 in a research report report published on Monday morning, Benzinga reports. The brokerage currently has a neutral rating on... More of this article »
Image about Antero Resources (NYSE:AR) Price Target Raised to $27.00 at Morgan Stanley

Antero Resources (NYSE:AR) Price Target Raised to $27.00 at Morgan Stanley

Antero Resources (NYSE:AR – Free Report) had its target price raised by Morgan Stanley from $26.00 to $27.00 in a report published on Monday morning, Benzinga reports. Morgan Stanley currently has an equal weight rating on the... More of this article »
Image about Azul (NYSE:AZUL) Receives Outperform Rating from Raymond James

Azul (NYSE:AZUL) Receives Outperform Rating from Raymond James

Raymond James reiterated their outperform rating on shares of Azul (NYSE:AZUL – Free Report) in a report released on Monday morning, Benzinga reports. Raymond James currently has a $12.00 price objective on the stock, down from... More of this article »
Image about American International Group (NYSE:AIG) Price Target Increased to $79.00 by Analysts at Morgan Stanley

American International Group (NYSE:AIG) Price Target Increased to $79.00 by Analysts at Morgan Stanley

American International Group (NYSE:AIG – Free Report) had its price objective increased by Morgan Stanley from $72.00 to $79.00 in a research report report published on Monday, Benzinga reports. The brokerage currently has an... More of this article »